SlideShare ist ein Scribd-Unternehmen logo
1 von 35
Cannabis as Medicine:
Redefining the Paradigm of the Doctor Patient Relationship 

JACK B. D’ANGELO,M.D.,M.B.A
Chief Medical Officer, CITIVA LLC

In today’s presentation we will discuss:
• The challenges Physicians Face with Cannabis
Therapies
• The Medical Model of Patient Care and
Cannabis
What is a Medical Marijuana Program?
Medical Cannabis, commonly referred to as Medical
Marijuana or MMJ simply refers to the use of various
forms of the cannabis plant in the treatment of medical
conditions.
• “Medical Marijuana Program”
• Term used in most state statutes, rules, and regulations
that provide for the medical use, cultivation and
dispensing of cannabis for medical purposes, which may or
may not include specific medical conditions for which a
physician (or other licensed health care provider) may
issue a recommendation, attestation, or authorization for
a patient to obtain and use cannabis.
How Far We Have Come
Cannabis use in patient care has increased in
popularity nationwide since 1996 when California
voters passed Proposition 215, making it the first
state to allow cannabis to be recommended in
patient care
Currently, 29 states and the District of Columbia and
Guam* have enacted laws or passed ballot initiatives
establishing comprehensive medical cannabis programs.
*As May 2017
Cannabis vs. Marijuana- 

What should 

we call it? 

• There are a lot of slang terms for cannabis. Some are hip, some are pejorative and
some are downright amusing.
• The term “marijuana,” given its history and the nature of prohibition, raises
eyebrows still today. Marijuana is what prohibition supporters called cannabis as
they sought to demonize its use and criminalize its consumers.  
• According to H.L. Mencken there are no known examples of the use of this word
prior to 1894. It became identified as the "devil’s weed" by early supporters of
prohibition, and many Americans don't know any other name for the cannabis
plant. 
Words Matter
Cannabis is an elegant botanical compound.
It is important to call things by the correct name.
For purposes of speaking about it’s use medically,
I use the term Cannabis.
Using this term with patients as well as in our
government will help people feel more comfortable
with its medical use and legitimacy, and allow us to
think beyond the stigma of recreational use.
Recommending Cannabis
Most doctors today either have patients asking
them about their opinion on using medical
cannabis, or are requesting a recommendation
for its use.
Many doctors face hurdles in finding the right
research, becoming ‘certified’ in recommending
cannabis, and/or are reluctant to enter into
non-traditional therapy with their patients.
So where do you begin to determine if its right
for your patient and your practice?
Getting Past the Obstacles to
Recommendation
• Fear
– Is it safe?
– Will all my patients need to get ‘high’ ?
– Will I be stigmatized?
– Will my patients have legitimate need?
– How will this affect my license?
• Time
– I have to take a class?
– I have even more paperwork?
– I can’t fit in any more patients or spend more time with them!
– It’s just easier all around to write a prescription
• Education
– This wasn’t taught in medical school…
– Where can I learn more about cannabis in patient therapies?
– What are the most recent studies? Why aren’t there more studies?
• Costs
– Patients require more visits, which in turn costs everyone more
– Medication costs aren’t covered by insurance
Getting Past the Fear- Patient Safety
• Patient Safety
– Cannabis has fewer side affects than any current opioid on the market
– There is not a single documented case of overdose on medical cannabis in
the world
– Cannabis therapies, when monitored by a physician, can have better
efficacy and fewer side affects than current Rx therapies.
– Not all THC is the same.
• Many, if not most, patients and even physicians correlate cannabis with ‘getting
high’. It is stigmatized by the recreational market and reinforced through years
of prohibition and purposeful misinformation
• In cannabis studies, you find that many conditions can be effectively treated
with cannabis that is well balanced in both CBD and THC or low to zero THC.
– No, your patient doesn’t need to ‘smoke’ their medication
• In almost all states where medical cannabis has been legalized, smoke-able
forms are not allowed.
• The most common and affective methods of dosing are tinctures, metered- dose
vaporization, capsules, and nasal spray.
Getting Past the Fear-
Manufacturing Safety
• Manufacturing Safety
– Medical cannabis in all 29 states
is tracked from seed to sale
through integrated software
systems.
– Independent tests are done at
each stage of product
development to ensure the
quality and safety of each
product
Getting Past the Fear- 

My Medical License
• Is there risk to my medical license?
– Physicians cannot legally prescribe marijuana. The Drug Enforcement
Administration classifies it as a Schedule I drug under the Controlled Substances
Act, the same class as heroin and LSD.
• The official federal policy is that marijuana has no accepted medical use and has a
high potential for abuse.
– Physicians can only write letters of recommendation that the patient qualifies
for a certification to use the substance, and only after a thorough examination
and often other state-specific requirements.
• Physicians cannot dispense marijuana.
• The patient must go to a licensed dispensary to obtain the drug.
– In 2013, the US Department of Justice advised US attorneys not to pursue
actions against physicians in states that allow medical marijuana.
• The goal of federal policy is to prevent distribution of marijuana to minors; prevent
sales revenue from going to criminal enterprises, gangs, and cartels; prevent diversion
from legal to non-legal states.
Getting Past the Fear- 

Will my patient base change?

Many may fear the stigma that has been
associated with cannabis use for many years.
However, medicine is still a science, and
science is telling us as physicians that cannabis is a
true medical therapy and should be considered for
many symptoms and illnesses.
With some of the biggest breakthroughs in
cannabis treatment coming from low-dose THC
therapies for epileptic children, our communities
are becoming very receptive to cannabis therapies
and are looking to their physicians for guidance,
education, and treatment.
The Real Faces of Cannabis Patients
*Source: MarijuanaPatients.org
Finding Time & The Ease of Traditional Rx
There is a very real challenge facing both physicians
and patients in starting a cannabis therapy program.
TIME
Writing a traditional prescription requires little time for the physician,
and a simple and known method of fulfilling that Rx for the patient.
Many physicians avoid recommending cannabis due to the ‘red tape’
required to comply with state regulations, and patients are often
overwhelmed and confused by the process to seek the medication.
There really is no way around this issue- the decision to work with
your patients and recommend medical cannabis in their treatments
requires your time and your willingness to educate yourself and your
patients in an ongoing relationship.
The Lack of Cannabis Therapy Research
• What has caused the lack of research?
• Due to the classification of cannabis as a schedule 1
drug, access to legal cannabis for medical research has
been restricted. Not only is access restricted, but all
research in the US has been done on single source THC.
• Some of the most promising medical research is being
conducted outside of the US. However, there are
sufficient studies for education and understanding of
its benefits, limitations, and indications of potential
uses in a variety of medical therapies.
Finding the Research
It can be challenging to cut through the myths
of cannabis curing everything to nothing.
As Physicians, we are challenged to continue
to educate ourselves and our patients to
determine the best possible treatments
options.
• Attend your state and local conferences
• Explore physician led webinars
• Good online resources
• WebMD
• “Medical Marijuana: What the Research Shows”
• www.TheCannabist.co
• “The 5 Most Important Medical Marijuana
Research Studies of 2016
• VISIT A DISPENSARY
•Almost all offer tours
Avoiding the Obstacles- Cost
• Cost to the Physician and to the Patient
• One of the biggest hurdles preventing patient access to
cannabis is the cost burden to both patient and physician
• Physician must pay for and take a state required course
• Patients must pay out of pocket- often for multiple visits just to get a
recommendation
• Insurance WILL NOT cover cannabis as medicine
• There are synthetic drugs coming to market that synthesize some of the
properties of THC. However, studies have continued to show that the entourage
affect of the whole plant is necessary in the most successful studies.
• There is no immediate solution to the costs for either
party.
• It will take the support and activism of us all to work through
the regulation hurdles to have cannabis recognized as
medicine federally, and continued growth in the market to
keep medication costs down for patients.
We Got Here Together,

Now Let’s Work Together
How Do Physicians and Patients
Work Together to Redefine
the Patient Doctor Relationship in the
over-regulated world of medical
cannabis?
Defining the Right Medical Model in this New Industry
• The solution to current medical-cannabis laws is not a
matter of supporting or prohibiting its use- with 29 states
allowing medical use, the role of the medical caretakers is
of the utmost importance.
• A proper medical model has always been composed of the
prescribing of medicine by a licensed prescriber and the
dispensing of medicine by a separate licensed entity, with
attention to appropriate dosing and therapeutic use.
Uh oh!
But we aren’t ‘Prescribing’ cannabis,
and there is no ‘Pharmacy’ for
dispensing.
Qualifying Conditions in the State of Florida
In the State of Florida, conditions approved for treatment
with cannabis are limited to the following*
•Cancer
•Epilepsy
•Glaucoma
•HIV/AIDS
•PTSD
•ALS or Lou Gehrig’s disease
•Crohn’s disease
•Parkinson’s disease
•Multiple sclerosis
•Other debilitating conditions of the same kind or class for which a
physician believes the use of cannabis would likely outweigh the
potential health risks for a patient.
Sticking to the Basics
Physician
Patient
Relationship
Patient
Evaluation
Informed and
Shared
Decision Making
Treatment Plan
& Ongoing
Management
• The health and well-being of patients depends upon a
collaborative effort between the physician and the patient.
• The relationship is complex and based on the mutual
understanding of the shared responsibility for the patient’s
health care.
• Establish knowledge of their history- Prior to providing a
recommendation, attestation, or authorization for cannabis to the
patient.
• At minimum, providers should have completed their state
mandated certifying course.
• Seek the continued education on cannabis therapies.
Research and patient databases are growing quickly as
medicinal use spreads, allowing for a community of caregivers
to make informed decisions and help educate their patients.
• VISIT A DISPENSARY
• Be familiar with their process, environment and staff. Know
what your patient will experience so that you can help them
understand the process.
The physician-patient relationship is fundamental to the
provision of acceptable medical care.
Patient Evaluation
• Documented in-person medical evaluation and collection of relevant
clinical history commensurate with the presentation of the patient
must be obtained before a decision is made as to whether to
recommend cannabis for medical use.
• Evaluation should include the patient’s history of present illness, social
history, past medical and surgical history, alcohol and substance use
history, family history with emphasis on addiction or mental illness/
psychotic disorders, physical exam, documentation of therapies with
inadequate response, and diagnosis requiring the cannabis
recommendation.
Informed & Shared Decision Making
• SHARE THE DECISION
• The decision to recommend cannabis should be a shared decision
between the physician and the patient.
• DISCUSS THE RISKS
• The physician should discuss the risks and benefits of the use of
cannabis with the patient.
• DISCUSS DOSAGE
• Patients should be advised of the variability of cannabis preparations
and the varying effects. The physician should explain proper dosing
(start low) and monitor the patient carefully.
• Be a Part of the Conversation
• Our community relies on our collective knowledge. Patients’
own education about cannabis and history of effectiveness is
often greater than many physicians. Encourage
communication and participate in available forums.
Treatment Agreement
A health care professional should document a written treatment
plan that includes:
• Review of other measures attempted to ease the suffering caused by the
terminal or debilitating medical condition that do not involve the
recommendation of cannabis.
• Some states, including Florida, have required several months of
alternative treatment before recommending cannabis.
• Advice about other options for managing the terminal or debilitating
medical condition.
• Determination that the patient with a
terminal or debilitating medical condition
may benefit from the recommendation of
cannabis.
Advice about the potential risks of the medical use of cannabis to
include:
• The variability of quality and concentration of cannabis, especially when
not purchased from a licensed dispensary.
• The risk of cannabis use disorder;
• Exacerbation of psychotic disorders and adverse cognitive effects for
children and young adults;
• Adverse events, exacerbation of psychotic disorder, adverse cognitive
effects for children and young adults, and other risks, including falls or
fractures;
• Use of cannabis during pregnancy or breast feeding;
• The need to safeguard all cannabis and cannabis-infused products from
children and pets or domestic animals; and
• The need to notify the patient that the cannabis is for the patient’s use
only and should not be donated or otherwise supplied to another
individual.
Advisement of Risks
Advice about the potential risks of the medical use of cannabis to
include:
• Where available, the physician recommending cannabis should register with the
appropriate oversight agency and provide the registry with information each time
a recommendation, attestation, authorization, or reauthorization is issued.
• Where available, the physician recommending cannabis should check the state
Prescription Drug Monitoring Program (PDMP) each time a recommendation,
attestation, authorization, or reauthorization is issued.
• The physician should regularly assess the patient’s response to the use of cannabis
and overall health and level of function. This assessment should include the
efficacy of the treatment to the patient, the goals of the treatment, and the
progress of those goals
Ongoing Management & Adapting the Treatment Plan
Consultation & Referral, Partner with Peers
It is the responsibility of a health care provider to have a holistic
consultation with their patients. It is important to partner with or
refer to other health care providers as needed to provide the best
overall care.
A patient who has a history of substance use disorder or a co-
occurring mental health disorder may require specialized
assessment and treatment.
The physician should seek a consultation with, or refer the patient
to, a pain management, psychiatric, addiction or mental health
specialist, as needed.
Accurate Medical Records
The physician should keep accurate and
complete medical records. Information that should appear in the
medical record includes, but is not necessarily limited to the
following:
• The patient’s medical history, including a review of prior medical
records as appropriate;
• Results of the physical examination, patient evaluation, diagnostic,
therapeutic, and laboratory results;
• Other treatments and prescribed medications;
• Authorization, attestation or recommendation for cannabis, to
include date, expiration, and any additional information required by state
statute;
• Instructions to the patient, including discussions of risks and
benefits, side effects and variable effects;
• Results of ongoing assessment and monitoring of patient’s response
to the use of cannabis;
• A copy of the signed Treatment Agreement, including instructions on
safekeeping and instructions on not sharing.
Physician Conflicts of Interest
A physician who recommends cannabis should not have a professional
office located at a dispensary or cultivation center or receive financial
compensation from or hold a financial interest in a dispensary or
cultivation center.
Now, Let’s Go Off and
Thank You
www.CITIVA.com jdangelo@citiva.com

Weitere ähnliche Inhalte

Was ist angesagt?

Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenOPUNITE
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioOPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleOPUNITE
 
Ethics legalization of marijuana.final online.pdf
Ethics legalization of marijuana.final online.pdfEthics legalization of marijuana.final online.pdf
Ethics legalization of marijuana.final online.pdfSasha Nazarchuk
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldOPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerOPUNITE
 
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeonRx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeonOPUNITE
 
Rx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerRx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerOPUNITE
 
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriend
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriendRx16 tpp tues_330_1_gavin_2saddy_3gastfriend
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriendOPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanOPUNITE
 
Web only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasWeb only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasOPUNITE
 
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armaganRx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armaganOPUNITE
 
Rx16 pharma wed_1115_1_ryle_2menkhaus_3mcginley
Rx16 pharma wed_1115_1_ryle_2menkhaus_3mcginleyRx16 pharma wed_1115_1_ryle_2menkhaus_3mcginley
Rx16 pharma wed_1115_1_ryle_2menkhaus_3mcginleyOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceOPUNITE
 
Ethics of advising medical marijuana practitioners 4.13.18
Ethics of advising medical marijuana practitioners 4.13.18Ethics of advising medical marijuana practitioners 4.13.18
Ethics of advising medical marijuana practitioners 4.13.18Darshan Kulkarni
 
ethics in medical use of marijuana
ethics in medical use of marijuanaethics in medical use of marijuana
ethics in medical use of marijuanaMudasir Khan
 
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welchRx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welchOPUNITE
 
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdevaRx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdevaOPUNITE
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynoteOPUNITE
 

Was ist angesagt? (20)

Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Ethics legalization of marijuana.final online.pdf
Ethics legalization of marijuana.final online.pdfEthics legalization of marijuana.final online.pdf
Ethics legalization of marijuana.final online.pdf
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeonRx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
 
Rx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerRx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2waller
 
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriend
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriendRx16 tpp tues_330_1_gavin_2saddy_3gastfriend
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriend
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Web only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasWeb only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haas
 
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armaganRx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
 
Rx16 pharma wed_1115_1_ryle_2menkhaus_3mcginley
Rx16 pharma wed_1115_1_ryle_2menkhaus_3mcginleyRx16 pharma wed_1115_1_ryle_2menkhaus_3mcginley
Rx16 pharma wed_1115_1_ryle_2menkhaus_3mcginley
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Ethics of advising medical marijuana practitioners 4.13.18
Ethics of advising medical marijuana practitioners 4.13.18Ethics of advising medical marijuana practitioners 4.13.18
Ethics of advising medical marijuana practitioners 4.13.18
 
ethics in medical use of marijuana
ethics in medical use of marijuanaethics in medical use of marijuana
ethics in medical use of marijuana
 
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welchRx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
 
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdevaRx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 

Ähnlich wie Cannabis as Medicine: Redefining the Paradigm of the Doctor-Patient Relationship by Jack D'Angelo, MD

Policies, procedures and protocols for legal cannabis therapy 2015
Policies, procedures and protocols for legal cannabis therapy 2015Policies, procedures and protocols for legal cannabis therapy 2015
Policies, procedures and protocols for legal cannabis therapy 2015Sue Rosen RN CLNC
 
The Benefits of Having a Medical Marijuana Card.pptx
The Benefits of Having a Medical Marijuana Card.pptxThe Benefits of Having a Medical Marijuana Card.pptx
The Benefits of Having a Medical Marijuana Card.pptxMedical Marijuana Card Queens
 
SAM - marijuana and the workplace
SAM - marijuana and the workplaceSAM - marijuana and the workplace
SAM - marijuana and the workplaceSAM
 
Sep182016Update About Ginger Google Slide Presentation
Sep182016Update About Ginger Google Slide PresentationSep182016Update About Ginger Google Slide Presentation
Sep182016Update About Ginger Google Slide PresentationGinger Mace
 
Cannabis dispensary – Is It Safe to Open One?
Cannabis dispensary – Is It Safe to Open One?Cannabis dispensary – Is It Safe to Open One?
Cannabis dispensary – Is It Safe to Open One?DashThomas
 
Beyond Certification: Navigating Legal Situations as a Medical Marijuana Pati...
Beyond Certification: Navigating Legal Situations as a Medical Marijuana Pati...Beyond Certification: Navigating Legal Situations as a Medical Marijuana Pati...
Beyond Certification: Navigating Legal Situations as a Medical Marijuana Pati...Benjamin Gelassen, MBA
 
The use of conplementary and alternative medicine (
The use of conplementary and alternative medicine (The use of conplementary and alternative medicine (
The use of conplementary and alternative medicine (SamboGlo
 
Marketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalMarketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalJorgeventura2014
 
Marketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalMarketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalGeorgi Daskalov
 
College Student Perceptions of Marijuana 2015
College Student Perceptions of Marijuana 2015College Student Perceptions of Marijuana 2015
College Student Perceptions of Marijuana 2015SarahMartin33
 
Criminal Law Compliance For Healthcare Professionals - Painkiller Law
Criminal Law Compliance For Healthcare Professionals - Painkiller LawCriminal Law Compliance For Healthcare Professionals - Painkiller Law
Criminal Law Compliance For Healthcare Professionals - Painkiller LawMeister Law Offices
 
Polypharmacy - What next? (Planning for Wessex) Workshop - Clare Howard's pre...
Polypharmacy - What next? (Planning for Wessex) Workshop - Clare Howard's pre...Polypharmacy - What next? (Planning for Wessex) Workshop - Clare Howard's pre...
Polypharmacy - What next? (Planning for Wessex) Workshop - Clare Howard's pre...Health Innovation Wessex
 
Medical Cannabis & Mito Disease
Medical Cannabis & Mito DiseaseMedical Cannabis & Mito Disease
Medical Cannabis & Mito Diseasemitoaction
 
Understanding the Endo-Cannabinoid System and Usage of Medical Cannabis in Ma...
Understanding the Endo-Cannabinoid System and Usage of Medical Cannabis in Ma...Understanding the Endo-Cannabinoid System and Usage of Medical Cannabis in Ma...
Understanding the Endo-Cannabinoid System and Usage of Medical Cannabis in Ma...tgregoryhowcm
 
Ph 1 harris hanna_slack
Ph 1 harris hanna_slackPh 1 harris hanna_slack
Ph 1 harris hanna_slackOPUNITE
 

Ähnlich wie Cannabis as Medicine: Redefining the Paradigm of the Doctor-Patient Relationship by Jack D'Angelo, MD (20)

Policies, procedures and protocols for legal cannabis therapy 2015
Policies, procedures and protocols for legal cannabis therapy 2015Policies, procedures and protocols for legal cannabis therapy 2015
Policies, procedures and protocols for legal cannabis therapy 2015
 
The Benefits of Having a Medical Marijuana Card.pptx
The Benefits of Having a Medical Marijuana Card.pptxThe Benefits of Having a Medical Marijuana Card.pptx
The Benefits of Having a Medical Marijuana Card.pptx
 
SAM - marijuana and the workplace
SAM - marijuana and the workplaceSAM - marijuana and the workplace
SAM - marijuana and the workplace
 
Chapter 3
Chapter 3Chapter 3
Chapter 3
 
Sep182016Update About Ginger Google Slide Presentation
Sep182016Update About Ginger Google Slide PresentationSep182016Update About Ginger Google Slide Presentation
Sep182016Update About Ginger Google Slide Presentation
 
Presentation1
Presentation1Presentation1
Presentation1
 
Cannabis dispensary – Is It Safe to Open One?
Cannabis dispensary – Is It Safe to Open One?Cannabis dispensary – Is It Safe to Open One?
Cannabis dispensary – Is It Safe to Open One?
 
Psp3 presentation
Psp3 presentation Psp3 presentation
Psp3 presentation
 
Beyond Certification: Navigating Legal Situations as a Medical Marijuana Pati...
Beyond Certification: Navigating Legal Situations as a Medical Marijuana Pati...Beyond Certification: Navigating Legal Situations as a Medical Marijuana Pati...
Beyond Certification: Navigating Legal Situations as a Medical Marijuana Pati...
 
The use of conplementary and alternative medicine (
The use of conplementary and alternative medicine (The use of conplementary and alternative medicine (
The use of conplementary and alternative medicine (
 
Marketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalMarketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_final
 
Marketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_finalMarketing and promotion_facts_071108_final
Marketing and promotion_facts_071108_final
 
Comp 2 powerpoint
Comp 2 powerpoint Comp 2 powerpoint
Comp 2 powerpoint
 
College Student Perceptions of Marijuana 2015
College Student Perceptions of Marijuana 2015College Student Perceptions of Marijuana 2015
College Student Perceptions of Marijuana 2015
 
Criminal Law Compliance For Healthcare Professionals - Painkiller Law
Criminal Law Compliance For Healthcare Professionals - Painkiller LawCriminal Law Compliance For Healthcare Professionals - Painkiller Law
Criminal Law Compliance For Healthcare Professionals - Painkiller Law
 
Polypharmacy - What next? (Planning for Wessex) Workshop - Clare Howard's pre...
Polypharmacy - What next? (Planning for Wessex) Workshop - Clare Howard's pre...Polypharmacy - What next? (Planning for Wessex) Workshop - Clare Howard's pre...
Polypharmacy - What next? (Planning for Wessex) Workshop - Clare Howard's pre...
 
Medical Cannabis & Mito Disease
Medical Cannabis & Mito DiseaseMedical Cannabis & Mito Disease
Medical Cannabis & Mito Disease
 
Medication adherence
Medication adherenceMedication adherence
Medication adherence
 
Understanding the Endo-Cannabinoid System and Usage of Medical Cannabis in Ma...
Understanding the Endo-Cannabinoid System and Usage of Medical Cannabis in Ma...Understanding the Endo-Cannabinoid System and Usage of Medical Cannabis in Ma...
Understanding the Endo-Cannabinoid System and Usage of Medical Cannabis in Ma...
 
Ph 1 harris hanna_slack
Ph 1 harris hanna_slackPh 1 harris hanna_slack
Ph 1 harris hanna_slack
 

Kürzlich hochgeladen

Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Celine George
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...Nguyen Thanh Tu Collection
 
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptxAUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptxiammrhaywood
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxAnupkumar Sharma
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPCeline George
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Celine George
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfVanessa Camilleri
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...Postal Advocate Inc.
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...JojoEDelaCruz
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPCeline George
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptxmary850239
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxAshokKarra1
 

Kürzlich hochgeladen (20)

YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptxYOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
 
Raw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptxRaw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptx
 
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptxAUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERP
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17
 
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptxYOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdf
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERP
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptx
 

Cannabis as Medicine: Redefining the Paradigm of the Doctor-Patient Relationship by Jack D'Angelo, MD

  • 1.
  • 2. Cannabis as Medicine: Redefining the Paradigm of the Doctor Patient Relationship 
 JACK B. D’ANGELO,M.D.,M.B.A Chief Medical Officer, CITIVA LLC

  • 3. In today’s presentation we will discuss: • The challenges Physicians Face with Cannabis Therapies • The Medical Model of Patient Care and Cannabis
  • 4. What is a Medical Marijuana Program? Medical Cannabis, commonly referred to as Medical Marijuana or MMJ simply refers to the use of various forms of the cannabis plant in the treatment of medical conditions. • “Medical Marijuana Program” • Term used in most state statutes, rules, and regulations that provide for the medical use, cultivation and dispensing of cannabis for medical purposes, which may or may not include specific medical conditions for which a physician (or other licensed health care provider) may issue a recommendation, attestation, or authorization for a patient to obtain and use cannabis.
  • 5. How Far We Have Come Cannabis use in patient care has increased in popularity nationwide since 1996 when California voters passed Proposition 215, making it the first state to allow cannabis to be recommended in patient care
  • 6. Currently, 29 states and the District of Columbia and Guam* have enacted laws or passed ballot initiatives establishing comprehensive medical cannabis programs. *As May 2017
  • 7. Cannabis vs. Marijuana- 
 What should 
 we call it? 
 • There are a lot of slang terms for cannabis. Some are hip, some are pejorative and some are downright amusing. • The term “marijuana,” given its history and the nature of prohibition, raises eyebrows still today. Marijuana is what prohibition supporters called cannabis as they sought to demonize its use and criminalize its consumers.   • According to H.L. Mencken there are no known examples of the use of this word prior to 1894. It became identified as the "devil’s weed" by early supporters of prohibition, and many Americans don't know any other name for the cannabis plant. 
  • 8. Words Matter Cannabis is an elegant botanical compound. It is important to call things by the correct name. For purposes of speaking about it’s use medically, I use the term Cannabis. Using this term with patients as well as in our government will help people feel more comfortable with its medical use and legitimacy, and allow us to think beyond the stigma of recreational use.
  • 9. Recommending Cannabis Most doctors today either have patients asking them about their opinion on using medical cannabis, or are requesting a recommendation for its use. Many doctors face hurdles in finding the right research, becoming ‘certified’ in recommending cannabis, and/or are reluctant to enter into non-traditional therapy with their patients. So where do you begin to determine if its right for your patient and your practice?
  • 10. Getting Past the Obstacles to Recommendation • Fear – Is it safe? – Will all my patients need to get ‘high’ ? – Will I be stigmatized? – Will my patients have legitimate need? – How will this affect my license? • Time – I have to take a class? – I have even more paperwork? – I can’t fit in any more patients or spend more time with them! – It’s just easier all around to write a prescription • Education – This wasn’t taught in medical school… – Where can I learn more about cannabis in patient therapies? – What are the most recent studies? Why aren’t there more studies? • Costs – Patients require more visits, which in turn costs everyone more – Medication costs aren’t covered by insurance
  • 11. Getting Past the Fear- Patient Safety • Patient Safety – Cannabis has fewer side affects than any current opioid on the market – There is not a single documented case of overdose on medical cannabis in the world – Cannabis therapies, when monitored by a physician, can have better efficacy and fewer side affects than current Rx therapies. – Not all THC is the same. • Many, if not most, patients and even physicians correlate cannabis with ‘getting high’. It is stigmatized by the recreational market and reinforced through years of prohibition and purposeful misinformation • In cannabis studies, you find that many conditions can be effectively treated with cannabis that is well balanced in both CBD and THC or low to zero THC. – No, your patient doesn’t need to ‘smoke’ their medication • In almost all states where medical cannabis has been legalized, smoke-able forms are not allowed. • The most common and affective methods of dosing are tinctures, metered- dose vaporization, capsules, and nasal spray.
  • 12. Getting Past the Fear- Manufacturing Safety • Manufacturing Safety – Medical cannabis in all 29 states is tracked from seed to sale through integrated software systems. – Independent tests are done at each stage of product development to ensure the quality and safety of each product
  • 13. Getting Past the Fear- 
 My Medical License • Is there risk to my medical license? – Physicians cannot legally prescribe marijuana. The Drug Enforcement Administration classifies it as a Schedule I drug under the Controlled Substances Act, the same class as heroin and LSD. • The official federal policy is that marijuana has no accepted medical use and has a high potential for abuse. – Physicians can only write letters of recommendation that the patient qualifies for a certification to use the substance, and only after a thorough examination and often other state-specific requirements. • Physicians cannot dispense marijuana. • The patient must go to a licensed dispensary to obtain the drug. – In 2013, the US Department of Justice advised US attorneys not to pursue actions against physicians in states that allow medical marijuana. • The goal of federal policy is to prevent distribution of marijuana to minors; prevent sales revenue from going to criminal enterprises, gangs, and cartels; prevent diversion from legal to non-legal states.
  • 14. Getting Past the Fear- 
 Will my patient base change?
 Many may fear the stigma that has been associated with cannabis use for many years. However, medicine is still a science, and science is telling us as physicians that cannabis is a true medical therapy and should be considered for many symptoms and illnesses. With some of the biggest breakthroughs in cannabis treatment coming from low-dose THC therapies for epileptic children, our communities are becoming very receptive to cannabis therapies and are looking to their physicians for guidance, education, and treatment.
  • 15. The Real Faces of Cannabis Patients *Source: MarijuanaPatients.org
  • 16. Finding Time & The Ease of Traditional Rx There is a very real challenge facing both physicians and patients in starting a cannabis therapy program. TIME Writing a traditional prescription requires little time for the physician, and a simple and known method of fulfilling that Rx for the patient. Many physicians avoid recommending cannabis due to the ‘red tape’ required to comply with state regulations, and patients are often overwhelmed and confused by the process to seek the medication. There really is no way around this issue- the decision to work with your patients and recommend medical cannabis in their treatments requires your time and your willingness to educate yourself and your patients in an ongoing relationship.
  • 17. The Lack of Cannabis Therapy Research • What has caused the lack of research? • Due to the classification of cannabis as a schedule 1 drug, access to legal cannabis for medical research has been restricted. Not only is access restricted, but all research in the US has been done on single source THC. • Some of the most promising medical research is being conducted outside of the US. However, there are sufficient studies for education and understanding of its benefits, limitations, and indications of potential uses in a variety of medical therapies.
  • 18. Finding the Research It can be challenging to cut through the myths of cannabis curing everything to nothing. As Physicians, we are challenged to continue to educate ourselves and our patients to determine the best possible treatments options. • Attend your state and local conferences • Explore physician led webinars • Good online resources • WebMD • “Medical Marijuana: What the Research Shows” • www.TheCannabist.co • “The 5 Most Important Medical Marijuana Research Studies of 2016 • VISIT A DISPENSARY •Almost all offer tours
  • 19. Avoiding the Obstacles- Cost • Cost to the Physician and to the Patient • One of the biggest hurdles preventing patient access to cannabis is the cost burden to both patient and physician • Physician must pay for and take a state required course • Patients must pay out of pocket- often for multiple visits just to get a recommendation • Insurance WILL NOT cover cannabis as medicine • There are synthetic drugs coming to market that synthesize some of the properties of THC. However, studies have continued to show that the entourage affect of the whole plant is necessary in the most successful studies. • There is no immediate solution to the costs for either party. • It will take the support and activism of us all to work through the regulation hurdles to have cannabis recognized as medicine federally, and continued growth in the market to keep medication costs down for patients.
  • 20. We Got Here Together,
 Now Let’s Work Together
  • 21. How Do Physicians and Patients Work Together to Redefine the Patient Doctor Relationship in the over-regulated world of medical cannabis?
  • 22. Defining the Right Medical Model in this New Industry • The solution to current medical-cannabis laws is not a matter of supporting or prohibiting its use- with 29 states allowing medical use, the role of the medical caretakers is of the utmost importance. • A proper medical model has always been composed of the prescribing of medicine by a licensed prescriber and the dispensing of medicine by a separate licensed entity, with attention to appropriate dosing and therapeutic use. Uh oh! But we aren’t ‘Prescribing’ cannabis, and there is no ‘Pharmacy’ for dispensing.
  • 23. Qualifying Conditions in the State of Florida In the State of Florida, conditions approved for treatment with cannabis are limited to the following* •Cancer •Epilepsy •Glaucoma •HIV/AIDS •PTSD •ALS or Lou Gehrig’s disease •Crohn’s disease •Parkinson’s disease •Multiple sclerosis •Other debilitating conditions of the same kind or class for which a physician believes the use of cannabis would likely outweigh the potential health risks for a patient.
  • 24. Sticking to the Basics Physician Patient Relationship Patient Evaluation Informed and Shared Decision Making Treatment Plan & Ongoing Management
  • 25. • The health and well-being of patients depends upon a collaborative effort between the physician and the patient. • The relationship is complex and based on the mutual understanding of the shared responsibility for the patient’s health care. • Establish knowledge of their history- Prior to providing a recommendation, attestation, or authorization for cannabis to the patient. • At minimum, providers should have completed their state mandated certifying course. • Seek the continued education on cannabis therapies. Research and patient databases are growing quickly as medicinal use spreads, allowing for a community of caregivers to make informed decisions and help educate their patients. • VISIT A DISPENSARY • Be familiar with their process, environment and staff. Know what your patient will experience so that you can help them understand the process. The physician-patient relationship is fundamental to the provision of acceptable medical care.
  • 26. Patient Evaluation • Documented in-person medical evaluation and collection of relevant clinical history commensurate with the presentation of the patient must be obtained before a decision is made as to whether to recommend cannabis for medical use. • Evaluation should include the patient’s history of present illness, social history, past medical and surgical history, alcohol and substance use history, family history with emphasis on addiction or mental illness/ psychotic disorders, physical exam, documentation of therapies with inadequate response, and diagnosis requiring the cannabis recommendation.
  • 27. Informed & Shared Decision Making • SHARE THE DECISION • The decision to recommend cannabis should be a shared decision between the physician and the patient. • DISCUSS THE RISKS • The physician should discuss the risks and benefits of the use of cannabis with the patient. • DISCUSS DOSAGE • Patients should be advised of the variability of cannabis preparations and the varying effects. The physician should explain proper dosing (start low) and monitor the patient carefully. • Be a Part of the Conversation • Our community relies on our collective knowledge. Patients’ own education about cannabis and history of effectiveness is often greater than many physicians. Encourage communication and participate in available forums.
  • 28. Treatment Agreement A health care professional should document a written treatment plan that includes: • Review of other measures attempted to ease the suffering caused by the terminal or debilitating medical condition that do not involve the recommendation of cannabis. • Some states, including Florida, have required several months of alternative treatment before recommending cannabis. • Advice about other options for managing the terminal or debilitating medical condition. • Determination that the patient with a terminal or debilitating medical condition may benefit from the recommendation of cannabis.
  • 29. Advice about the potential risks of the medical use of cannabis to include: • The variability of quality and concentration of cannabis, especially when not purchased from a licensed dispensary. • The risk of cannabis use disorder; • Exacerbation of psychotic disorders and adverse cognitive effects for children and young adults; • Adverse events, exacerbation of psychotic disorder, adverse cognitive effects for children and young adults, and other risks, including falls or fractures; • Use of cannabis during pregnancy or breast feeding; • The need to safeguard all cannabis and cannabis-infused products from children and pets or domestic animals; and • The need to notify the patient that the cannabis is for the patient’s use only and should not be donated or otherwise supplied to another individual. Advisement of Risks
  • 30. Advice about the potential risks of the medical use of cannabis to include: • Where available, the physician recommending cannabis should register with the appropriate oversight agency and provide the registry with information each time a recommendation, attestation, authorization, or reauthorization is issued. • Where available, the physician recommending cannabis should check the state Prescription Drug Monitoring Program (PDMP) each time a recommendation, attestation, authorization, or reauthorization is issued. • The physician should regularly assess the patient’s response to the use of cannabis and overall health and level of function. This assessment should include the efficacy of the treatment to the patient, the goals of the treatment, and the progress of those goals Ongoing Management & Adapting the Treatment Plan
  • 31. Consultation & Referral, Partner with Peers It is the responsibility of a health care provider to have a holistic consultation with their patients. It is important to partner with or refer to other health care providers as needed to provide the best overall care. A patient who has a history of substance use disorder or a co- occurring mental health disorder may require specialized assessment and treatment. The physician should seek a consultation with, or refer the patient to, a pain management, psychiatric, addiction or mental health specialist, as needed.
  • 32. Accurate Medical Records The physician should keep accurate and complete medical records. Information that should appear in the medical record includes, but is not necessarily limited to the following: • The patient’s medical history, including a review of prior medical records as appropriate; • Results of the physical examination, patient evaluation, diagnostic, therapeutic, and laboratory results; • Other treatments and prescribed medications; • Authorization, attestation or recommendation for cannabis, to include date, expiration, and any additional information required by state statute; • Instructions to the patient, including discussions of risks and benefits, side effects and variable effects; • Results of ongoing assessment and monitoring of patient’s response to the use of cannabis; • A copy of the signed Treatment Agreement, including instructions on safekeeping and instructions on not sharing.
  • 33. Physician Conflicts of Interest A physician who recommends cannabis should not have a professional office located at a dispensary or cultivation center or receive financial compensation from or hold a financial interest in a dispensary or cultivation center.
  • 34. Now, Let’s Go Off and